Sharpening the Sword—HymonBio Wins the “Star of Creation” Cup

The 7^th China Experimental Medicine Conference (CEMC) was held on October 25^th and 26^th at the conference center in the Greenfield Platinum Hotel, during the Nanchang International Expo City. The leading theme was about Leading Opportunities—The Future After the Epidemic. The award was sponsored by the Experimental Medicine Branch of the National Health Industry Enterprise Management Association, the Medical Laboratory Industry Branch of the National Health Industry Enterprise Management Association, and the In Vitro Diagnosis Branch of the China Medical Device Industry Association.

The Hymon^®SARS-Cov-2 Test Kit won the “Star of Creation” Cup—the gold medal for China’s annual excellent innovative product in vitro diagnosis. Dr. Tan, CEO of the company, was invited to attend ceremony and received the award on the stage.

The company’s innovative “one-step method” effectively solves the cumbersome nucleic acid extraction process: nucleic acid is automatically released in 3 minutes, with sample-to-results in 30 minutes at the fastest. Based on nanobody molecular lock technology (MoLock) and double internal standard design, it achieves high sensitivity, high specificity, and whole-process monitoring.

Technical Features and Product Advantages

Rapid detection: “One-step method” allows sample-to-results in 30 minutes.

Accurate and safe: Targets N and E genes for double insurance.

Multiple monitoring: Unique DIDC dual internal standard technology performs quality control during sample and testing processes.

Unique technology: Unique MoLock technology improves sensitivity and specificity

High sensitivity: Up to 200 copies/mL.

Received FDA EUA and cited by former FDA commissioner.

The product has been verified by the Clinical Laboratory Center of the National Health Commission of China, the Microbiology and Devices Department of the US FDA, the King’s College Hospital NHS Foundation in the UK, the Laboratory of the Hong Kong Polytechnic University affiliated to the Hong Kong Department of Health and other authoritative institutions. So far it detects 100% of COVID-19 variants, including but not limited to: Alpha, Beta, Gamma, Delta, Omicron and others. It has passed US FDA EUA certification, EU CE and other national qualifications. It has been reported by more than 30 overseas English media, and has been mentioned by former US FDA commissioner Dr. Stephen M. Hahn, on his official Twitter account.